Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Capricorn Energy optimistic after 'pivotal' year

(Sharecast News) - Capricorn Energy said on Thursday that 2024 had been a "pivotal" year for the oil and gas producer, with crucial negotiations with the Egyptian authorities on track to conclude in the coming months. The London-listed, Egyptian-focused firm said that along with operating partner Cheiron Oil and Gas, it had made "good" progress towards consolidating its eight concession agreements in the country into a single, integrated agreement.

It said the process was expected to conclude in the current year, ahead of final approval by the Egyptian authorities.

A new agreement would support increase production and strengthen returns, it noted.

The update came as Capricorn posted full-year production of 23,763 barrels of equivalent per day, down on last year's 30,044 boepd but at the upper end of internal guidance.

Revenues from production were $147m, down on the previous year's $200m, compounded by an easing in the average price per barrel, to $79.3 from $81.2.

Debt stood at $100m as at 31 December 2024, and cash at $132m. Profits from discounted operations were $23m, while losses from continuing operations were $12m.

Randy Neely, chief executive, said: "2024 was a pivotal year for Capricorn, during which we continued to improve the operational performance of the Egyptian business and continued our culture of financial discipline, which helped the company achieve the upper end of production guidance.

"Growth and diversification of operations and cash flows will be a key focus for 2025. Our goal is to ultimately deliver consistent shareholder returns, and we are evaluating M&A opportunities in the UK North Sea and MENA region, through a strict set of financial and strategic criteria, to facilitate this."

James Hosie, analyst at Shore Capital, said: "[Capricorn's] results statement is essentially a progress report while the business sits at a critical point in management's business plan to unlock value.

"In this context, the most noteworthy point is that discussion with the Egyptian authorities to consolidate and extend eight of its concession agreements under improved terms remain on track to complete during the 2025 full-year.

"Once confirmed, Capricorn should be able to outline a plan for reserves and production growth."

As at 0830 GMT, shares in Capricorn were trading 5% lower at 244.0p.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.